Changes of biological features in breast cancer cells determined by primary chemotherapy Antonio FrassoldatiFrancesca AdamiVittorio Silingardi OriginalPaper Pages: 185 - 192
Breast conserving therapy in stage I & II breast cancer in Korea Hy-De LeeDong-Sup YoonKi-Keun Oh OriginalPaper Pages: 193 - 199
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer Michael CrumpCarol A. SawkaKathleen I. Pritchard OriginalPaper Pages: 201 - 210
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1 Carol A. SawkaKathleen I. PritchardDonald J.A. Sutherland OriginalPaper Pages: 211 - 215
Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture William Small Jr.Agostino MolteniWilliam F. Ward OriginalPaper Pages: 217 - 224
Risk factors for breast cancer: A case-control study of screen-detected breast cancer in Miyagi Prefecture, Japan Yuko MinamiNoriaki OhuchiShigeru Hisamichi OriginalPaper Pages: 225 - 233
Associations of alcohol, height, and reproductive factors with serum hormone concentrations in postmenopausal Japanese women Chisato NagataMichinori KabutoHiroyuki Shimizu OriginalPaper Pages: 235 - 241
Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: Promoter usage and alternative mRNA splicing Carla M. Shaw-BruhaSamuel J. PirrucelloJames D. Shull OriginalPaper Pages: 243 - 253
Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients M. ZambettiR. DemicheliG. Bonadonna OriginalPaper Pages: 255 - 260
Cd44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas Nathalie GuriecBéatrice GairardFrancis Oberling OriginalPaper Pages: 261 - 268
Hepatic toxicity caused by adjuvant CMF/CNF in breast cancer patients and reversal by tamoxifen Pasi P. HirvikoskiEero J. KumpulainenRisto T. Johansson OriginalPaper Pages: 269 - 274
Brca2 hereditary breast cancer pathophenotype Joseph N. MarcusPatrice WatsonHenry T. Lynch BriefCommunication Pages: 275 - 277
